MA26951A1 - Derives de pyrazole pour le traitement de maladies virales - Google Patents

Derives de pyrazole pour le traitement de maladies virales

Info

Publication number: MA26951A1
Authority: MA; Morocco
Prior art keywords: treatment; viral diseases; pyrazole derivatives; pyrazole; derivatives
Prior art date: 2000-10-10

Application number

MA27096A

Other languages

English (en)

Inventor

Brian William Dymock

Philip Stephen Jones

John Herbert Merrett

Martin John Parratt

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-10

Filing date

2003-04-07

Publication date

2004-12-20

2003-04-07 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26951A1 publication Critical patent/MA26951A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MA27096A 2000-10-10 2003-04-07 Derives de pyrazole pour le traitement de maladies virales MA26951A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0024795.7A GB0024795D0 (en)	2000-10-10	2000-10-10	Pyrazole derivatives for the treatment of viral diseases

Publications (1)

Publication Number	Publication Date
MA26951A1 true MA26951A1 (fr)	2004-12-20

Family

ID=9900999

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27096A MA26951A1 (fr)	2000-10-10	2003-04-07	Derives de pyrazole pour le traitement de maladies virales

Country Status (28)

Country	Link
US (2)	US6699887B2 (fr)
EP (1)	EP1326843A1 (fr)
JP (1)	JP4015548B2 (fr)
KR (1)	KR100534158B1 (fr)
CN (2)	CN1680333A (fr)
AR (1)	AR030858A1 (fr)
AU (2)	AU2165102A (fr)
BR (1)	BR0114483A (fr)
CA (1)	CA2423515A1 (fr)
CZ (1)	CZ20031297A3 (fr)
EC (1)	ECSP034547A (fr)
GB (1)	GB0024795D0 (fr)
GT (1)	GT200100201A (fr)
HR (1)	HRP20030251A2 (fr)
HU (1)	HUP0302722A2 (fr)
IL (1)	IL154875A0 (fr)
MA (1)	MA26951A1 (fr)
MX (1)	MXPA03003070A (fr)
NO (1)	NO20031615L (fr)
NZ (1)	NZ524740A (fr)
PA (1)	PA8530301A1 (fr)
PE (1)	PE20020750A1 (fr)
PL (1)	PL362918A1 (fr)
RU (1)	RU2270832C2 (fr)
UY (1)	UY26956A1 (fr)
WO (1)	WO2002030907A1 (fr)
YU (1)	YU27203A (fr)
ZA (1)	ZA200302519B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1598067B1 (fr) *	2000-09-29	2009-05-06	TopoTarget UK Limited	Derivées d'acide de carbamine contenant un group amide pour la traitement de malaria
GB0113524D0 (en) *	2001-06-04	2001-07-25	Hoffmann La Roche	Pyrazole derivatives
US7230025B2 (en)	2002-09-26	2007-06-12	Pfizer, Inc.	Pyrazole derivatives
JP2006504803A (ja) *	2002-09-26	2006-02-09	ファイザー・インク	ピラゾール誘導体
MXPA05002004A (es)	2002-09-26	2005-04-28	Pfizer	Derivados de pirazol.
US6933312B2 (en)	2002-10-07	2005-08-23	Agouron Pharmaceuticals, Inc.	Pyrazole derivatives
GB0223234D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
GB0223232D0 (en) *	2002-10-07	2002-11-13	Pfizer Ltd	Chemical compounds
TW200423930A (en) *	2003-02-18	2004-11-16	Hoffmann La Roche	Non-nucleoside reverse transcriptase inhibitors
KR20050119652A (ko)	2003-03-24	2005-12-21	에프. 호프만-라 로슈 아게	역전사 효소 저해제로서의 벤질-피리다진온
US7220772B2 (en)	2003-09-05	2007-05-22	Pfizer, Inc.	Pyrazole derivatives
CA2569530C (fr) *	2004-07-01	2013-07-30	Daiichi Asubio Pharma Co.,Ltd.	Derive de thienopyrazole ayant une activite d'inhibition de la pde 7
US20070005049A1 (en) *	2005-06-30	2007-01-04	Comben Richard H	Apparatus and Method of Treating Urinary Incontinence by Heating Urethra
EP2046774A1 (fr) *	2006-07-05	2009-04-15	Pfizer Products Inc.	Dérivés de pyrazole utilisés en tant qu'inhibiteurs du cytochrome p450
WO2008019968A1 (fr)	2006-08-16	2008-02-21	F. Hoffmann-La Roche Ag	Inhibiteurs de la transcriptase inverse non nucléoside
GB0713479D0 (en) *	2007-07-11	2007-08-22	Syngenta Participations Ag	Substituted aromatic heterocyclic compounds as fungicides
EP2225239B1 (fr)	2007-12-21	2014-10-22	F. Hoffmann-La Roche AG	Composés hétérocycliques antiviraux
GB0823000D0 (en) *	2008-12-17	2009-01-28	Syngenta Participations Ag	Isothiazole and pyrazole derivatives with plant growth regulating properties
WO2010098344A1 (fr)	2009-02-25	2010-09-02	第一三共株式会社	Dérivé de pyrazolopyrimidine tricyclique
FR2951549B1 (fr)	2009-10-15	2013-08-23	Olivier Schussler	Procede d'obtention de bioprotheses medicales implantables
KR20130099006A (ko)	2010-08-23	2013-09-05	다이이찌 산쿄 가부시키가이샤	3 고리성 피라졸로피리미딘 유도체의 프리체 결정
JP5701884B2 (ja)	2010-08-23	2015-04-15	第一三共株式会社	三環性ピラゾロピリミジン誘導体の結晶
US9695127B2 (en)	2012-11-08	2017-07-04	University of Pittsburgh—of the Commonwealth System of Higher Education	Compounds for treating HIV and methods for using the compounds
US9925190B2 (en)	2015-02-16	2018-03-27	University of Pittsburgh—of the Commonwealth System of Higher Education	Small molecules targeting HIV-1 Nef
EP3778583B1 (fr)	2018-03-30	2025-06-18	Sumitomo Chemical Company, Limited	Composé hétérocyclique et agent de lutte contre les arthropodes nuisibles le contenant
WO2020081856A1 (fr) *	2018-10-18	2020-04-23	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Inhibiteurs de hiv-1 nef pour le traitement d'une infection par le vih
FR3121927B1 (fr)	2021-04-19	2023-03-31	Eiffage Genie Civil Terrassement	Procédé d’inertage des boues d’excavation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993015060A1 (fr)	1992-01-22	1993-08-05	Nissan Chemical Industries, Ltd.	Derive de pyrazole substitue et bactericide agrohorticole
US6005109A (en)	1997-10-30	1999-12-21	Pflizer Inc.	Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
PL175831B1 (pl) *	1992-12-17	1999-02-26	Pfizer	Pochodna pirazolu
TW336932B (en) *	1992-12-17	1998-07-21	Pfizer	Amino-substituted pyrazoles
ATE187451T1 (de) *	1992-12-17	1999-12-15	Pfizer	Substituierte pyrazole als crf antagonisten
WO2006027423A1 (fr) *	2004-08-09	2006-03-16	Simag Developpement	Dispositif de saisie comportant un capteur optique suivi d’un moyen de filtrage

2000
- 2000-10-10 GB GBGB0024795.7A patent/GB0024795D0/en not_active Ceased
2001
- 2001-09-20 US US09/956,656 patent/US6699887B2/en not_active Expired - Fee Related
- 2001-10-04 CA CA002423515A patent/CA2423515A1/fr not_active Abandoned
- 2001-10-04 HU HU0302722A patent/HUP0302722A2/hu unknown
- 2001-10-04 IL IL15487501A patent/IL154875A0/xx unknown
- 2001-10-04 WO PCT/EP2001/011474 patent/WO2002030907A1/fr not_active Ceased
- 2001-10-04 PL PL01362918A patent/PL362918A1/xx not_active Application Discontinuation
- 2001-10-04 CZ CZ20031297A patent/CZ20031297A3/cs unknown
- 2001-10-04 AU AU2165102A patent/AU2165102A/xx active Pending
- 2001-10-04 CN CNA2005100088329A patent/CN1680333A/zh active Pending
- 2001-10-04 KR KR10-2003-7004984A patent/KR100534158B1/ko not_active Expired - Fee Related
- 2001-10-04 EP EP01986680A patent/EP1326843A1/fr not_active Withdrawn
- 2001-10-04 RU RU2003112610/04A patent/RU2270832C2/ru not_active IP Right Cessation
- 2001-10-04 BR BR0114483-9A patent/BR0114483A/pt not_active Application Discontinuation
- 2001-10-04 HR HR20030251A patent/HRP20030251A2/hr not_active Application Discontinuation
- 2001-10-04 AU AU2002221651A patent/AU2002221651B2/en not_active Ceased
- 2001-10-04 JP JP2002534293A patent/JP4015548B2/ja not_active Expired - Fee Related
- 2001-10-04 NZ NZ524740A patent/NZ524740A/en unknown
- 2001-10-04 YU YU27203A patent/YU27203A/sh unknown
- 2001-10-04 CN CNB018171710A patent/CN1191239C/zh not_active Expired - Fee Related
- 2001-10-04 MX MXPA03003070A patent/MXPA03003070A/es active IP Right Grant
- 2001-10-05 AR ARP010104697A patent/AR030858A1/es not_active Application Discontinuation
- 2001-10-05 PE PE2001000993A patent/PE20020750A1/es not_active Application Discontinuation
- 2001-10-09 PA PA20018530301A patent/PA8530301A1/es unknown
- 2001-10-09 UY UY26956A patent/UY26956A1/es not_active Application Discontinuation
- 2001-10-09 GT GT200100201A patent/GT200100201A/es unknown
2003
- 2003-03-31 ZA ZA200302519A patent/ZA200302519B/en unknown
- 2003-04-07 MA MA27096A patent/MA26951A1/fr unknown
- 2003-04-08 EC EC2003004547A patent/ECSP034547A/es unknown
- 2003-04-09 NO NO20031615A patent/NO20031615L/no unknown
2004
- 2004-01-27 US US10/766,712 patent/US7183296B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7183296B2 (en)	2007-02-27
RU2270832C2 (ru)	2006-02-27
GB0024795D0 (en)	2000-11-22
EP1326843A1 (fr)	2003-07-16
WO2002030907A1 (fr)	2002-04-18
RU2003112610A (ru)	2005-02-20
AU2002221651B2 (en)	2006-10-19
US20030018197A1 (en)	2003-01-23
KR100534158B1 (ko)	2005-12-06
PE20020750A1 (es)	2002-08-21
CN1680333A (zh)	2005-10-12
PL362918A1 (en)	2004-11-02
YU27203A (sh)	2006-05-25
ZA200302519B (en)	2004-06-30
HK1061021A1 (en)	2004-09-03
KR20030046492A (ko)	2003-06-12
US20040192752A1 (en)	2004-09-30
UY26956A1 (es)	2002-04-26
AU2165102A (en)	2002-04-22
JP4015548B2 (ja)	2007-11-28
AR030858A1 (es)	2003-09-03
IL154875A0 (en)	2003-10-31
CN1469865A (zh)	2004-01-21
BR0114483A (pt)	2003-07-01
NZ524740A (en)	2005-09-30
CZ20031297A3 (cs)	2004-01-14
JP2004511469A (ja)	2004-04-15
NO20031615D0 (no)	2003-04-09
HRP20030251A2 (en)	2005-02-28
NO20031615L (no)	2003-05-23
CN1191239C (zh)	2005-03-02
MXPA03003070A (es)	2003-07-14
CA2423515A1 (fr)	2002-04-18
GT200100201A (es)	2002-05-23
ECSP034547A (es)	2003-05-26
PA8530301A1 (es)	2002-07-30
US6699887B2 (en)	2004-03-02
HUP0302722A2 (hu)	2003-12-29

Publication	Publication Date	Title
MA26951A1 (fr)	2004-12-20	Derives de pyrazole pour le traitement de maladies virales
DZ3500A1 (fr)	2002-09-29	Derives de phenethanolamine pour le traitement de maladies respiratoires
EP1311261A4 (fr)	2004-06-02	Medicaments pour le traitement chimiotherapeutique de maladies
ATE556059T1 (de)	2012-05-15	Pyrazolderivate zur behandlung von hiv
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
FR15C0070I2 (fr)	2016-02-12	Composes heteroaromatiques azotes pour le traitement des maladies de cancer
NO20031442L (no)	2003-05-26	Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20030443D0 (no)	2003-01-28	Fremgangsmåte for fremstilling av funksjonelle proteindomener
DK1764111T3 (da)	2010-04-06	Vaginalt indgivne anti-dysrytmi midler til behandling af uterin dysrytmi
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
DE50013843D1 (de)	2007-01-18	Arzneimittel zur behandlung von darmerkrankungen
ATE276262T1 (de)	2004-10-15	Oxazinochinolone für die behandlung viraler infektionen
EE05308B1 (et)	2010-06-15	Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
DK1468996T3 (da)	2008-01-07	Indolderivater til behandling af CNS-sygdomme
NO20032769D0 (no)	2003-06-18	Kombinasjonsmetode for behandling av virale infeksjoner
DE60005685D1 (de)	2003-11-06	Oxazinocarbazole zur behandlung von cns-erkrankungen
DE60114448D1 (de)	2005-12-01	Imidazolonderivate zur behandlung viraler krankheiten
ATE343387T1 (de)	2006-11-15	S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
NO20033290D0 (no)	2003-07-21	Pyrrolderivater for behandling av cytokinformidlede sykdommer
EP1304117A4 (fr)	2005-04-27	Remedes pour maladies osseuses
FR2806293B1 (fr)	2002-09-27	Implants scleraux pour le traitement du decollement de retine
EP1410795A4 (fr)	2005-08-03	Remedes pour maladies oculaires allergiques
FR2824727B1 (fr)	2004-01-16	Orthese du pouce pour le traitement des entorses metacarpo-phalangiennes
FR2804331B1 (fr)	2002-03-29	Valve pour le traitement de l'hydrocephalie
EP1244467A4 (fr)	2005-01-05	Phosphoglycerate kinase dans le traitement de maladies